- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00050960
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer
July 7, 2012 updated by: Eisai Inc.
Randomized Phase III Trial Comparing Targretin Capsules/Carboplatin/Paclitaxel Versus Carboplatin/Paclitaxel in Chemotherapy-Naïve Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
This study evaluates the use of Targretin capsules (bexarotene) in combination with standard chemotherapy for the treatment of metastatic Non-Small Cell Lung Cancer (NSCLC) in patients who have not yet received chemotherapy for their lung cancer.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study evaluates the use of Targretin capsules (bexarotene) in combination with Carboplatin and Paclitaxel for the treatment of metastatic non-small cell lung cancer in patients who have not yet received chemotherapy for their lung cancer.
Every patient receives a platinum-containing chemotherapy every three weeks for at least four chemotherapy cycles (approximately four months).
Half of the patients are randomly assigned to receive Targretin capsules once daily in addition to the chemotherapy.
The other half is randomized to receive a standard platinum-containing chemotherapy without Targretin capsules.
Study Type
Interventional
Enrollment (Actual)
612
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Wels, Austria, 4600
- Allgemeines offentliches Krankenhaus der barmherzigen Schwestern vom Heiligen Kreuz Pneumologie
-
Wien, Austria, 1145
- Sozialmedizinisches Zentrum
-
Wien, Austria, A-1100
- Kaiser-Franz-Josef-Spital
-
-
-
-
Ontario
-
Sault Ste. Marie, Ontario, Canada, P6A 2C4
- Algoma Regional Cancer Program - Sault Area Hospital
-
Weston, Ontario, Canada, M9N 1N8
- Humber River Regional Hospital
-
-
Quebec
-
Montreal, Quebec, Canada, H3T 1E2
- S.M.B.D. Jewish General Hospital
-
-
-
-
-
Aix en Provence, Cedex 01, France, 13616
- Centre Hospitalier du Pays d'Aix
-
Annecy Cedex, France, 47011
- Centre Hospitalier General de la Region Annecienne
-
Antibes Cedex, France, 06606
- Centre Hospitalier d'Antibes-Juan-Les-Pins
-
Bois Guillaume, France, 76230
- CHRU Hopital de Bois Guillaume
-
Creteil, France, 94010
- DOP International
-
Draguignan, France, 83300
- Hopital de Draguignan
-
Gap Cedex, France, 05007
- Centre Hospitalier Général
-
Limoges Cedex, France, 87042
- Hôpital du Cluzeau
-
Marseille, Cedex 09, France, 29274
- CHU Hopital St. Marguerite
-
Montpellier, Cedex 05, France, 34298
- Centre Regional de Lutte contre le Cancer (CRLC), Val d'Aurelle-Paul Lamarque
-
Paris, Cedex 12, France, 75571
- Hôpital Saint Antoine
-
St. Etienne, Cedex 2, France, 42055
- Chu - Hopital Nord
-
Toulon Naval, France, 83800
- Hôpital Saint Anne
-
Vandoeuvre les Nancy, France, 54511
- Service de Pneumology, Hopital Adulte de Brabois
-
Villefranche sur Soane, France, 69655
- Centre hospitalier
-
-
-
-
-
Andernach, Germany, D-56626
- Dept. of Internal Medicine, St. Nikolaus-Stiftshospital Andernach
-
Gauting, Germany, D-82131
- Aesklepios-Fachkliniken Muchen-Gauting
-
GroBhansdorf, Germany, 22927
- Krankenhaus GroBhansdorf, Zentrum fur Pneumologie und Thoraxchirurgie
-
Munchen, Germany, 80336
- Ludwig-Maximilians Universitat Munchen
-
SchumannstraBe, Berlin, Germany, 10117
- Charite Universitatsklinikum der Humboldt-Universitat zu Berlin
-
-
-
-
-
Castellon, Spain, 12002
- Hospital Provincial de Castellon
-
Madrid, Spain, 28040
- Hospital Clinico San Carlos
-
Valencia, Spain, 46 017
- Hospital Universitario Doctor Peset
-
Valencia, Spain, 46018
- Hospital Universitario La Fe Servicio de Oncologia
-
Valencia, Spain, 46039
- Hospital Arnau de Villanova, Servicio de Oncologia
-
Valencia, Spain, 46044
- Hospital Clinico Universitario, Servicio Hematologia y Oncologia
-
Valencia, Spain, 46520
- Hospital de Sagunto Servicio de Oncologia
-
-
-
-
Alabama
-
Montgomery, Alabama, United States, 36106
- Montgomery Cancer Center, L.L.C.
-
-
Arizona
-
Tucson, Arizona, United States, 85712
- Arizona Clinical Research Center, Inc.
-
-
California
-
Concord, California, United States, 94520
- Bay Area Cancer Research Group, LLC
-
Fountain Valley, California, United States, 92708
- Pacific Coast Hematology/Oncology Medical Group, Inc.
-
Fountain Valley, California, United States, 92708
- Compassionate Cancer Care Medical Group, Inc.
-
Greenbrae, California, United States, 94909
- California Cancer Care, Inc.
-
Long Beach, California, United States, 90806
- Coast Hematology and Oncology Associates
-
Los Angeles, California, United States, 90057
- Metropolitan Hematology/Oncology Medical Group
-
Los Angeles, California, United States, 90067
- Sant P. Chawla, Inc.
-
Los Angeles, California, United States, 94115
- UCLA Medical Center
-
Modesto, California, United States, 95355
- Sutter Gould Medical Foundation
-
Orange, California, United States, 92868
- Medical Oncology Care Associates
-
San Diego, California, United States, 92123
- SHARP Health Care
-
San Diego, California, United States, 92120
- Southern California Kaiser Permanente Medical Group
-
San Francisco, California, United States, 94115
- UCSF/Mount Zion Comprehensive Cancer Center
-
Vista, California, United States, 92083
- Medical Group of North County, Inc., San Diego Cancer Center
-
-
Colorado
-
Denver, Colorado, United States, 80218
- Rocky Mountain Cancer Centers - Midtown
-
-
Connecticut
-
Norwich, Connecticut, United States, 06360
- Eastern Connecticut Hematology & Oncology
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20007
- Georgetown University Hospital
-
Washington, District of Columbia, United States, 20010
- Washington Cancer Institute
-
-
Florida
-
Boca Raton, Florida, United States, 33428
- Comprehensive Cancer Care Specialists of Boca Raton
-
Jacksonville, Florida, United States, 32209
- University of Florida/Jacksonville
-
Lakeland, Florida, United States, 33805
- Watson Clinic
-
Miami, Florida, United States, 33133
- Oncology and Radiation Associates
-
New Port Richey, Florida, United States, 34652
- Florida Cancer Institute
-
Orange Park, Florida, United States, 32073
- Florida Oncology Associates
-
Orlando, Florida, United States, 32806
- Cancer Centers of Florida, P.A.
-
Plantation, Florida, United States, 33324
- South Florida Oncology & Hematology Consultants
-
-
Georgia
-
Augusta, Georgia, United States, 30901
- Medical Oncology Associates of Augusta
-
Marietta, Georgia, United States, 30060
- Georgia Oncology Partners Research & Education Foundation
-
-
Idaho
-
Boise, Idaho, United States, 83712
- St. Luke's/Mountain State Tumor Institute (MSTI)
-
-
Illinois
-
Chicago, Illinois, United States, 60640
- Weiss Memorial Hospital
-
Elk Grove Village, Illinois, United States, 60007
- Northwest Oncology and Hematology, SC
-
Park Ridge, Illinois, United States, 60068
- Lutheran General Cancer Care Center
-
Peoria, Illinois, United States, 61602
- Oncology/Hematology Associates of Central Illinois, P.C.
-
Skokie, Illinois, United States, 60077
- Hematology Oncology Assoc. of Illinois
-
-
Indiana
-
Indianapolis, Indiana, United States, 46227
- Central Indiana Cancer Centers
-
New Albany, Indiana, United States, 47150
- Cancer Care Center
-
South Bend, Indiana, United States, 46601
- Michiana Hematology-Oncology
-
-
Kansas
-
Overland Park, Kansas, United States, 66210
- Kansas City Oncology and Hematology Group, Kansas City Cancer Centers
-
-
Kentucky
-
Louisville, Kentucky, United States, 40215
- Drs. Carroll, Sheth, and Raghavan
-
-
Louisiana
-
Lafayette, Louisiana, United States, 70503
- Southwest Oncology Associates
-
Metairie, Louisiana, United States, 70006
- APMC
-
New Orleans, Louisiana, United States, 70112
- Tulane University Health Sciences Center
-
New Orleans, Louisiana, United States, 70112
- Louisiana State University Health Sciences Center
-
-
Maryland
-
Baltimore, Maryland, United States, 21202
- Mercy Medical Center
-
Baltimore, Maryland, United States, 21225
- Chesapeake Oncology-Hematology Associates
-
Rockville, Maryland, United States, 20850
- Associates in Oncology/Hematology PC
-
-
Massachusetts
-
Pittsfield, Massachusetts, United States, 01201
- Berkshire Hematology Oncology, PC
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan Medical Center
-
Southfield, Michigan, United States, 48075
- Providence Cancer Institute
-
-
Minnesota
-
Duluth, Minnesota, United States, 55805
- St. Lukes Hospital
-
Minneapolis, Minnesota, United States, 55407
- Minnesota Oncology Hematology, P.A.
-
-
Missouri
-
Columbia, Missouri, United States, 65201
- Missouri Cancer Associates
-
-
Montana
-
Billings, Montana, United States, 59101
- Hematology Oncology Centers of the Northern Rockies
-
Missoula, Montana, United States, 59802
- Montana Cancer & Infectious Disease Specialists
-
-
Nevada
-
Henderson, Nevada, United States, 89014
- Cancer and Blood Specialists of Nevada
-
Las Vegas, Nevada, United States, 89109
- Nevada Cancer Center
-
-
New Hampshire
-
Lebanon, New Hampshire, United States, 03756
- Dartmouth-Hitchcock Medical Center
-
-
New Jersey
-
East Orange, New Jersey, United States, 07018
- VA New Jersey Health Care System
-
East Orange, New Jersey, United States, 07018
- Orange Medical Group
-
Morristown, New Jersey, United States, 07962
- Hematology-Oncology Associates of Northern NJ, PA
-
Somerset, New Jersey, United States, 08873
- Somerset Hematology Oncology Associates
-
Stratford, New Jersey, United States, 08084
- University of Medicine & Dentistry of NJ, School of Osteopathic Medicine
-
Summit, New Jersey, United States, 07901
- Overlook Oncology Center
-
-
New Mexico
-
Farmington, New Mexico, United States, 87401
- San Juan Oncology Associates
-
-
New York
-
Albany, New York, United States, 12208
- New York Oncology Hematology, P.C., Capital District Hematology Oncology Associates
-
Buffalo, New York, United States, 14263
- Roswell Park Cancer Institute
-
Buffalo, New York, United States, 14215
- Erie Medical Center
-
Great Neck, New York, United States, 11021
- Arena Oncology Associates
-
Great Neck, New York, United States, 11023
- Cancer Institute of Long Island, Inc.
-
Great Neck, New York, United States, 11023
- Cancer Research of Long Island, Inc.
-
Johnson City, New York, United States, 13790
- Broome Oncology, LLC
-
New York, New York, United States, 10032
- Columbia Presbyterian Medical Center
-
New York, New York, United States, 10021
- New York Presbyterian Hospital, Weill Medical College of Cornell University
-
Northport, New York, United States, 11768
- VA Medical Center
-
Rexford, New York, United States, 12148
- New York Oncology Hematology, P.C., Riverview Cancer Care Medical Associates
-
Rockville Centre, New York, United States, 11570
- South Shore Hematology Oncology Associates, PC
-
-
North Carolina
-
Cary, North Carolina, United States, 27511
- Raleigh Hematology Oncology Clinic
-
Hickory, North Carolina, United States, 28602
- Northwest Carolina Oncology and Hematology, P.A.
-
-
Ohio
-
Canton, Ohio, United States, 44718
- Nashat Y. Gabrail, MD, Inc.
-
Cincinnati, Ohio, United States, 45219
- University of Cincinnati, Barrett Cancer Center
-
Columbus, Ohio, United States, 43206
- Columbus Community Clinical Oncology Program
-
Dayton, Ohio, United States, 45439
- Dayton Oncology/Hematology Consultants
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73104
- University of Oklahoma Health Sciences Center
-
Oklahoma City, Oklahoma, United States, 73120
- Cancer Care Associates - Mercy Campus
-
Tulsa, Oklahoma, United States, 74136
- Cancer Care Associates
-
-
Oregon
-
Portland, Oregon, United States, 97227
- Oncology/Hematology, Kaiser Permanente Northwest
-
-
Pennsylvania
-
Bethlehem, Pennsylvania, United States, 18015
- Oncology Hematology of Lehigh Valley, PC
-
Kingston, Pennsylvania, United States, 18704
- Medical Oncology Associates of Wyoming Valley, PC
-
-
South Carolina
-
Charleston, South Carolina, United States, 29403
- Charleston Hematology Oncology P.A.
-
Columbia, South Carolina, United States, 29209
- WJB Dorn VA Medical Center
-
Columbia, South Carolina, United States, 29203
- Liberty Hematology/Oncology
-
Seneca, South Carolina, United States, 29672
- Cancer Centers of the Carolinas
-
Sumter, South Carolina, United States, 29150
- Santee Hematology/Oncology
-
-
Tennessee
-
Knoxville, Tennessee, United States, 37916
- Thompson Cancer Survival Center
-
Memphis, Tennessee, United States, 38104
- Boston Baskin Cancer Group
-
-
Texas
-
Arlington, Texas, United States, 76012
- Texas Oncology, P.A.
-
Austin, Texas, United States, 78745
- South Austin Cancer Center
-
Austin, Texas, United States, 78759
- Lone Star Oncology Consultants, P.A.
-
Corpus Christi, Texas, United States, 78412
- Cancer Specialists Of South Texas, Pa
-
Dallas, Texas, United States, 75246
- Texas Oncology, P.A.
-
Dallas, Texas, United States, 75230
- Texas Cancer Center at Medical City
-
Fort Worth, Texas, United States, 76104
- Texas Oncology, P.A.
-
Garland, Texas, United States, 75042
- Texas Oncology, P.A.
-
Houston, Texas, United States, 77030
- University of Texas, MD Anderson Cancer Center
-
Midland, Texas, United States, 79701
- Allison Cancer Center
-
Odessa, Texas, United States, 79761
- West Texas Cancer Center
-
Richardson, Texas, United States, 75080
- HOPE Oncology
-
San Antonio, Texas, United States, 78229
- Hematology & Oncology Associates of South Texas
-
Tyler, Texas, United States, 75702
- Tyler Cancer Center
-
Wichita Falls, Texas, United States, 76310
- Texoma Cancer Center
-
-
Utah
-
Salt Lake City, Utah, United States, 84106
- Utah Cancer Specialists
-
-
Virginia
-
Arlington, Virginia, United States, 22205
- Arlington Fairfax Hematology Oncology
-
Charlottesville, Virginia, United States, 22902
- Hematology Oncology Patient Enterprises, Center for Cancer Care
-
Danville, Virginia, United States, 24541
- Danville Hematology & Oncology, Inc.
-
Norfolk, Virginia, United States, 23502
- Virginia Oncology Associates
-
Portsmouth, Virginia, United States, 23707
- Stark MD, PC
-
Richmond, Virginia, United States, 23230
- Virginia Cancer Institute
-
-
Washington
-
Yakima, Washington, United States, 98902
- Yakima Regional Cancer Care Center, Internal Medicine Associates of Yakima, Inc.
-
-
West Virginia
-
Morgantown, West Virginia, United States, 26505
- Morgantown Internal Medicine Group
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Patients must have:
- Pathologic (histologic or cytologic) confirmation of NSCLC
- Stage IIIB with malignant pleural effusion or Stage IV disease
- At least one measurable or evaluable NSCLC lesion that has not been previously irradiated unless radiation therapy was more than three weeks prior to entry in the study and the lesion has been shown to have progressed subsequent to the radiation therapy
- ECOG performance status 0 or 1
- Adequate organ system function
- Fasting serum triglycerides that are within the age-adjusted normal range (or normalized with appropriate intervention such as antilipid therapy prior to the initiation of Targretin capsule therapy).
Patients must be able to complete at least four cycles of combination chemotherapy (i.e., approximately four months)
Patients must not have had:
- Brain metastasis
- Prior chemotherapy for NSCLC
- Prior platinum-based chemotherapy for any indication
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: bexarotene with carboplatin and paclitaxel
|
bexarotene capsules (400 mg/m^2/day) in combination with carboplatin IV (AUC 6) every 3 weeks and paclitaxel IV (200 mg/m^2) every 3 weeks.
Subjects in this group also received an antilipid agent which was selected at the discretion of the investigator.
|
|
Experimental: carboplatin and paclitaxel
|
carboplatin IV (AUC 6) every 3 weeks and paclitaxel IV (200 mg/m^2) every 3 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Overall Survival
Time Frame: From date of randomization to date of death
|
From date of randomization to date of death
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Mack Mabry, M.D., Ligand Pharmaceuticals
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2002
Primary Completion (Actual)
July 1, 2004
Study Completion (Actual)
March 1, 2005
Study Registration Dates
First Submitted
December 31, 2002
First Submitted That Met QC Criteria
January 2, 2003
First Posted (Estimate)
January 3, 2003
Study Record Updates
Last Update Posted (Estimate)
July 13, 2012
Last Update Submitted That Met QC Criteria
July 7, 2012
Last Verified
July 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Respiratory Tract Diseases
- Neoplasms
- Lung Diseases
- Neoplasms by Site
- Respiratory Tract Neoplasms
- Thoracic Neoplasms
- Carcinoma, Bronchogenic
- Bronchial Neoplasms
- Lung Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Molecular Mechanisms of Pharmacological Action
- Antineoplastic Agents
- Tubulin Modulators
- Antimitotic Agents
- Mitosis Modulators
- Antineoplastic Agents, Phytogenic
- Carboplatin
- Paclitaxel
- Albumin-Bound Paclitaxel
- Bexarotene
Other Study ID Numbers
- L1069-48
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Non-small Cell Lung Cancer
-
WindMIL TherapeuticsBristol-Myers SquibbTerminatedNSCLC | Lung Cancer | Lung Cancer Metastatic | Lung Cancer, Non-small Cell | Non Small Cell Lung Cancer | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non Small Cell Lung Cancer MetastaticUnited States
-
University of California, San FranciscoAstraZenecaActive, not recruitingStage IIIA Non-Small Cell Lung Cancer | Stage I Non-Small Cell Lung Cancer | Stage IA Non-Small Cell Lung Cancer | Stage IB Non-Small Cell Lung Cancer | Stage II Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Cancer | Stage IIB Non-Small Cell Lung CancerUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)CompletedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Extensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Healthy, no Evidence of Disease | Limited Stage Small Cell Lung... and other conditionsUnited States
-
AIO-Studien-gGmbHBristol-Myers Squibb; Eli Lilly and Company; Merck Sharp & Dohme LLC; Pfizer; Gilead... and other collaboratorsRecruitingSmall-cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage I | Metastatic Non-small Cell Lung Cancer (NSCLC) | Non Small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer Stage IIGermany
-
University of California, DavisNational Cancer Institute (NCI)RecruitingNon Small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IV | Non-small Cell Lung Cancer Stage IIIC | Non-small Cell Lung Cancer UnresectableUnited States
-
Royal Marsden NHS Foundation TrustUniversity of Cambridge; Royal Brompton & Harefield NHS Foundation Trust; Institute... and other collaboratorsRecruitingNon Small Cell Lung Cancer | Metastatic Non Small Cell Lung Cancer | Locally Advanced NSCLC - Non-Small Cell Lung Cancer | Oncogene-addicted Non Small Cell Lung Cancer | Early-stage Operable Non Small Cell Lung Cancer | Stage 2/3 Operable Non Small Cell Lung CancerUnited Kingdom
-
Alexander ChiNot yet recruitingNon-small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage I | Non-small Cell Carcinoma | Non-small Cell Lung Cancer Stage IIChina
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Bristol-Myers SquibbTerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage I Non-Small Cell Lung Cancer | Stage II Non-Small Cell Lung Cancer | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung Carcinoma | Non-Squamous Non-Small...United States
-
Brigham and Women's HospitalFood and Drug Administration (FDA)Active, not recruitingAdvanced Non-squamous Non-small-cell Lung Cancer | Advanced Squamous Non Small Cell Lung CancerUnited States
-
Jiangxi Provincial People's HopitalNot yet recruitingNon-Small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IV | Non-small Cell Lung Cancer RecurrentChina
Clinical Trials on bexarotene with carboplatin and paclitaxel
-
Women's Hospital School Of Medicine Zhejiang UniversitySun Yat-sen University; Qilu Hospital of Shandong University; Second Affiliated... and other collaboratorsRecruitingEpithelial Ovarian Carcinoma Stage III | Epithelial Ovarian Carcinoma Stage IV | Fallopian Tube Carcinoma Stage III | Fallopian Tube Carcinoma Stage IV | Primary Peritoneal Carcinoma Stage III | Primary Peritoneal Carcinoma Stage IVChina
-
Sun Yat-sen UniversityRecruitingResectable Mucosal MelanomaChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.RecruitingEsophageal Squamous Cell Carcinoma (ESCC)China
-
Ligand PharmaceuticalsCompleted
-
Cancer Institute and Hospital, Chinese Academy...RecruitingChemotherapy Effect | Locally Advanced Breast CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityActive, not recruiting
-
AccentureCompletedRecurrent Platinum-resistant Ovarian CancerAustralia, Russian Federation, United Kingdom
-
Eisai Inc.CompletedNon-small Cell Lung CancerCanada, United States, United Kingdom, Australia, Israel, Russian Federation, Czech Republic, France, Greece, Hungary, Poland
-
Cancer Institute and Hospital, Chinese Academy...UnknownAdenocarcinoma | NSCLC | Squamous Cell Carcinoma
-
Centre Leon BerardCompletedFRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/Paclitaxel (FRAIL-IMMUNE)Squamous Cell Carcinoma of the Head and NeckFrance